Cargando…
Changes over Time in Patient Stated Values and Treatment Preferences Regarding Aggressive Therapies: Insights from the DECIDE-LVAD Trial
BACKGROUND: Patient-centered care includes matching treatments to patient values and preferences. This assumes clarity and consistency of values and preferences relevant to major medical decisions. We sought to describe stability of patient-reported values regarding aggressiveness of care and prefer...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8783927/ https://www.ncbi.nlm.nih.gov/pubmed/34296623 http://dx.doi.org/10.1177/0272989X211028234 |
_version_ | 1784638639256371200 |
---|---|
author | Knoepke, Christopher E. Chaussee, Erin L. Matlock, Daniel D. Thompson, Jocelyn S. McIlvennan, Colleen K. Ambardekar, Amrut V. Schaffer, Elisabeth M. Khazanie, Prateeti Scherer, Laura Arnold, Robert M. Allen, Larry A. |
author_facet | Knoepke, Christopher E. Chaussee, Erin L. Matlock, Daniel D. Thompson, Jocelyn S. McIlvennan, Colleen K. Ambardekar, Amrut V. Schaffer, Elisabeth M. Khazanie, Prateeti Scherer, Laura Arnold, Robert M. Allen, Larry A. |
author_sort | Knoepke, Christopher E. |
collection | PubMed |
description | BACKGROUND: Patient-centered care includes matching treatments to patient values and preferences. This assumes clarity and consistency of values and preferences relevant to major medical decisions. We sought to describe stability of patient-reported values regarding aggressiveness of care and preferences for left ventricular assist devices (LVADs) for advanced heart failure. METHODS AND RESULTS: We conducted a secondary analysis of patients undergoing LVAD evaluation at 6 US centers. Surveys at baseline, 1 month, and 6 months included a single 10-point scale on the value of aggressive care (score 1 = “do everything,” 10 = “live with whatever time I have left”) and treatment preference (LVAD, unsure, no LVAD). Data were captured for 232 patients, of whom 196 were ultimately deemed medically eligible for LVAD, and 161 were surgically implanted by 1 month. Values at baseline favored aggressive care (mean [SD], 2.49 [2.63]), trending toward less aggressive over time (1 month, 2.63 [2.05]; 6 months, 3.22 [2.70]). Between baseline and 1 month, values scores changed by ≥2 points in 28% (50/176), as did treatment preferences for 18% (29/161) of patients. Values score changes over time were associated with lower illness acceptance, depression, and eventual LVAD ineligibility. Treatment preference change was associated with values score change. CONCLUSION: Most patients considering LVAD were stable in their values and treatment preferences. This stability, as well as the association between unstable treatment preferences and changes to stated values, highlighted the clinical utility of the values scale of aggressiveness. However, a substantial minority reported significant changes over time that may complicate the process of shared decision making. Improved methods to elicit and clarify values, including support to those with depression and low illness acceptance, is critical for patient-centered care. |
format | Online Article Text |
id | pubmed-8783927 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-87839272022-03-15 Changes over Time in Patient Stated Values and Treatment Preferences Regarding Aggressive Therapies: Insights from the DECIDE-LVAD Trial Knoepke, Christopher E. Chaussee, Erin L. Matlock, Daniel D. Thompson, Jocelyn S. McIlvennan, Colleen K. Ambardekar, Amrut V. Schaffer, Elisabeth M. Khazanie, Prateeti Scherer, Laura Arnold, Robert M. Allen, Larry A. Med Decis Making Original Research Articles BACKGROUND: Patient-centered care includes matching treatments to patient values and preferences. This assumes clarity and consistency of values and preferences relevant to major medical decisions. We sought to describe stability of patient-reported values regarding aggressiveness of care and preferences for left ventricular assist devices (LVADs) for advanced heart failure. METHODS AND RESULTS: We conducted a secondary analysis of patients undergoing LVAD evaluation at 6 US centers. Surveys at baseline, 1 month, and 6 months included a single 10-point scale on the value of aggressive care (score 1 = “do everything,” 10 = “live with whatever time I have left”) and treatment preference (LVAD, unsure, no LVAD). Data were captured for 232 patients, of whom 196 were ultimately deemed medically eligible for LVAD, and 161 were surgically implanted by 1 month. Values at baseline favored aggressive care (mean [SD], 2.49 [2.63]), trending toward less aggressive over time (1 month, 2.63 [2.05]; 6 months, 3.22 [2.70]). Between baseline and 1 month, values scores changed by ≥2 points in 28% (50/176), as did treatment preferences for 18% (29/161) of patients. Values score changes over time were associated with lower illness acceptance, depression, and eventual LVAD ineligibility. Treatment preference change was associated with values score change. CONCLUSION: Most patients considering LVAD were stable in their values and treatment preferences. This stability, as well as the association between unstable treatment preferences and changes to stated values, highlighted the clinical utility of the values scale of aggressiveness. However, a substantial minority reported significant changes over time that may complicate the process of shared decision making. Improved methods to elicit and clarify values, including support to those with depression and low illness acceptance, is critical for patient-centered care. SAGE Publications 2021-07-23 2022-04 /pmc/articles/PMC8783927/ /pubmed/34296623 http://dx.doi.org/10.1177/0272989X211028234 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Original Research Articles Knoepke, Christopher E. Chaussee, Erin L. Matlock, Daniel D. Thompson, Jocelyn S. McIlvennan, Colleen K. Ambardekar, Amrut V. Schaffer, Elisabeth M. Khazanie, Prateeti Scherer, Laura Arnold, Robert M. Allen, Larry A. Changes over Time in Patient Stated Values and Treatment Preferences Regarding Aggressive Therapies: Insights from the DECIDE-LVAD Trial |
title | Changes over Time in Patient Stated Values and Treatment Preferences Regarding Aggressive Therapies: Insights from the DECIDE-LVAD Trial |
title_full | Changes over Time in Patient Stated Values and Treatment Preferences Regarding Aggressive Therapies: Insights from the DECIDE-LVAD Trial |
title_fullStr | Changes over Time in Patient Stated Values and Treatment Preferences Regarding Aggressive Therapies: Insights from the DECIDE-LVAD Trial |
title_full_unstemmed | Changes over Time in Patient Stated Values and Treatment Preferences Regarding Aggressive Therapies: Insights from the DECIDE-LVAD Trial |
title_short | Changes over Time in Patient Stated Values and Treatment Preferences Regarding Aggressive Therapies: Insights from the DECIDE-LVAD Trial |
title_sort | changes over time in patient stated values and treatment preferences regarding aggressive therapies: insights from the decide-lvad trial |
topic | Original Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8783927/ https://www.ncbi.nlm.nih.gov/pubmed/34296623 http://dx.doi.org/10.1177/0272989X211028234 |
work_keys_str_mv | AT knoepkechristophere changesovertimeinpatientstatedvaluesandtreatmentpreferencesregardingaggressivetherapiesinsightsfromthedecidelvadtrial AT chausseeerinl changesovertimeinpatientstatedvaluesandtreatmentpreferencesregardingaggressivetherapiesinsightsfromthedecidelvadtrial AT matlockdanield changesovertimeinpatientstatedvaluesandtreatmentpreferencesregardingaggressivetherapiesinsightsfromthedecidelvadtrial AT thompsonjocelyns changesovertimeinpatientstatedvaluesandtreatmentpreferencesregardingaggressivetherapiesinsightsfromthedecidelvadtrial AT mcilvennancolleenk changesovertimeinpatientstatedvaluesandtreatmentpreferencesregardingaggressivetherapiesinsightsfromthedecidelvadtrial AT ambardekaramrutv changesovertimeinpatientstatedvaluesandtreatmentpreferencesregardingaggressivetherapiesinsightsfromthedecidelvadtrial AT schafferelisabethm changesovertimeinpatientstatedvaluesandtreatmentpreferencesregardingaggressivetherapiesinsightsfromthedecidelvadtrial AT khazanieprateeti changesovertimeinpatientstatedvaluesandtreatmentpreferencesregardingaggressivetherapiesinsightsfromthedecidelvadtrial AT schererlaura changesovertimeinpatientstatedvaluesandtreatmentpreferencesregardingaggressivetherapiesinsightsfromthedecidelvadtrial AT arnoldrobertm changesovertimeinpatientstatedvaluesandtreatmentpreferencesregardingaggressivetherapiesinsightsfromthedecidelvadtrial AT allenlarrya changesovertimeinpatientstatedvaluesandtreatmentpreferencesregardingaggressivetherapiesinsightsfromthedecidelvadtrial |